Barely Significant
← all excerpts

Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation.

Bioengineering (Basel) · 2025 · PMC12467381 · PMID 41007217

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Results The evaluation of model performances shows that the SIDER dataset compounds showed a trend towards higher recall than precision ( Table 3 ), with rivaroxaban showing the highest recall (0.746), followed by dabigatran (0.702), and all models showing a higher precision and recall compared to the ConPlex model, which failed to attain satisfactory prediction in any of the tasks.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.